Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tamargo

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Discovery Medicine|December 4, 2012
Drug-induced atrial fibrillation: does it matter?Juan Tamargo, Ricardo Caballero, Eva Delpón
Expert Opinion on Pharmacotherapy|April 4, 2019
Pharmacotherapy for hypertension in pregnant patients: special considerationsJuan Tamargo, Ricardo Caballero, Eva Delpón
Expert Opinion on Investigational Drugs|September 5, 2022
Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipelineJuan Tamargo, María Tamargo, Ricardo Caballero
Expert Opinion on Drug Safety|June 26, 2012
Drug-induced atrial fibrillationJuan Tamargo, Ricardo Caballero, Eva Delpón
Cardiovascular Drugs and Therapy|January 27, 2018
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System InhibitorsJuan Tamargo, Ricardo Caballero, Eva Delpón
Current Medicinal Chemistry|February 3, 2004
Pharmacological approaches in the treatment of atrial fibrillationJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|January 13, 2022
Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of CardiotoxicityJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|January 12, 2015
Cancer chemotherapy and cardiac arrhythmias: a reviewJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|March 23, 2012
Safety of flecainideJuan Tamargo, Alessandro Capucci, Philippe Mabo
European Cardiology|October 4, 2021
ISCHEMIA Trial: Key Questions and AnswersJose Lopez-Sendon, Raúl Moreno, Juan Tamargo
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Discovery Medicine|December 4, 2012
Drug-induced atrial fibrillation: does it matter?Juan Tamargo, Ricardo Caballero, Eva Delpón
Expert Opinion on Pharmacotherapy|April 4, 2019
Pharmacotherapy for hypertension in pregnant patients: special considerationsJuan Tamargo, Ricardo Caballero, Eva Delpón
Expert Opinion on Investigational Drugs|September 5, 2022
Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipelineJuan Tamargo, María Tamargo, Ricardo Caballero
Expert Opinion on Drug Safety|June 26, 2012
Drug-induced atrial fibrillationJuan Tamargo, Ricardo Caballero, Eva Delpón
Cardiovascular Drugs and Therapy|January 27, 2018
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System InhibitorsJuan Tamargo, Ricardo Caballero, Eva Delpón
Current Medicinal Chemistry|February 3, 2004
Pharmacological approaches in the treatment of atrial fibrillationJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|January 13, 2022
Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of CardiotoxicityJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|January 12, 2015
Cancer chemotherapy and cardiac arrhythmias: a reviewJuan Tamargo, Ricardo Caballero, Eva Delpón
Drug Safety|March 23, 2012
Safety of flecainideJuan Tamargo, Alessandro Capucci, Philippe Mabo
European Cardiology|October 4, 2021
ISCHEMIA Trial: Key Questions and AnswersJose Lopez-Sendon, Raúl Moreno, Juan Tamargo
Pageof 19